Independent, user-validated findings in 2026 report reinforces Viz.ai's growing leadership over a competitive field as healthcare shifts to clinical AI infrastructure.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has been ranked No. 1 in the Black Book Research survey of AI Clinical Decision Support solutions for the second consecutive year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260409845426/en/

AI Clinical Decision Support Vendor Key Performance

Based on direct feedback from 1,237 healthcare professionals, including clinicians, administrators, and operational leaders across hospitals, health systems, and medical groups, the annual Black Book survey evaluates vendors on enterprise scalability, real-world performance across workflow integration, speed to intervention, care coordination, and analytics. Viz.ai ranked top overall, and No. 1 in the majority (13 of 18) of the categories, further reinforcing Viz.ai’s significant leadership position across the category.

Clinical AI has emerged as a core agentic infrastructure layer as health systems face growing pressure to improve outcomes while managing operational complexity. Healthcare organizations are moving beyond standalone AI tools and prioritizing enterprise platforms that operationalize insights by connecting detection, communication, and coordinated action across care teams. This is Viz.ai’s second consecutive No.1 ranking, positioning the company at the forefront of agentic AI in healthcare. Respondents highlighted Viz.ai’s ability to scale across the enterprise, and highlighted Viz.ai’s strength in enabling coordinated, multidisciplinary care across critical conditions, which include stroke, cardiovascular disease, pulmonary, and oncology.

“The Black Book survey stands apart by capturing what matters directly from the clinicians and administrators doing the work,” said Chris Mansi, MD, CEO and co-founder of Viz.ai. “Being ranked the #1 Clinical AI platform is especially meaningful in the era of agentic AI, because clinical workflow is where value in healthcare is created. It’s where agents act, and where they can directly improve patient outcomes, operational efficiency, and financial performance.”

Survey respondents rated Viz.ai highly across the capabilities most important to enterprise adoption, including:

• Deep integration across imaging, EHR, and clinical systems
• Scalability across service lines and care pathways
• Speed to alert and time-to-treatment acceleration
• Workflow orchestration and closed-loop communication
• Overall enterprise value and long-term performance confidence

This year’s results reflect a broader shift in the market. According to Black Book, providers are increasingly rewarding solutions that deliver end-to-end clinical impact across the enterprise, delivering both clinical and financial value. Viz.ai’s platform was consistently recognized for its ability to support the end-to-end workflow continuum, enabling agents to act where clinical work happens.

Learn more about the 2026 Black Book Research Report on AI Clinical Decision Support here.

About Viz.ai

Viz.ai is the leader in building and deploying AI-powered Care Pathways and helping doctors do their work. The Viz Platform is deployed in 2,000 hospitals across the United States and trusted by many of the leading life sciences companies. The platform uniquely combines real-time, multimodal clinical data with deep clinician engagement to detect disease earlier, coordinate care teams, and help ensure patients receive the right treatment faster. Viz.ai was the first company to be awarded CMS reimbursement for AI and is ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey. For more information, visit Viz.ai.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260409845426/en/